Literature DB >> 26728162

Human Radiation Dosimetry of [(18)F]AV-1451(T807) to Detect Tau Pathology.

Jae Yong Choi1, Chul Hyoung Lyoo2, Jae Hoon Lee1, Hanna Cho2, Kyeong Min Kim3, Jin Su Kim3, Young Hoon Ryu4.   

Abstract

PURPOSE: [(18)F]AV-1451 is a positron emission tomography (PET) radioligand for detecting paired helical filament tau. Our aim was to estimate the radiation dose of [(18)F]AV-1451 in humans. PROCEDURES: Whole-body PET scans were acquired for six healthy volunteers (three male, three female) for 128 min after injection of [(18)F]AV-1451 (268 ± 31 MBq). Radiation doses were estimated using the OLINDA/EXM software.
RESULTS: The estimated organ doses ranged from 7.81 to 81.2 μSv/MBq. The critical organ for radiation burden was the liver. Radiation doses to the reproductive and blood-forming organs were 14.15, 8.43, and 18.35 μSv/MBq for the ovaries, testes, and red marrow, respectively. The mean effective dose was 22.47 ± 3.59 μSv/MBq.
CONCLUSIONS: A standard single injection of 185 MBq (5 mCi) results in an effective dose of 4.7 mSv in a healthy subject. Therefore, [(18)F]AV-1451 could be used in multiple PET scans of the same subject per year.

Entities:  

Keywords:  Dosimetry; PET; Tau; [18F]AV-1451

Mesh:

Substances:

Year:  2016        PMID: 26728162     DOI: 10.1007/s11307-015-0924-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  14 in total

1.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors:  David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

Review 3.  Developments in Tau PET Imaging.

Authors:  Eduardo Rigon Zimmer; Antoine Leuzy; Serge Gauthier; Pedro Rosa-Neto
Journal:  Can J Neurol Sci       Date:  2014-09       Impact factor: 2.104

4.  [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Katsutoshi Furukawa; Aiko Ishiki; Naoki Tomita; Kotaro Hiraoka; Shoichi Watanuki; Miho Shidahara; Masayasu Miyake; Yoichi Ishikawa; Rin Matsuda; Akie Inami; Takeo Yoshikawa; Tetsuro Tago; Yoshihito Funaki; Ren Iwata; Manabu Tashiro; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-20       Impact factor: 9.236

Review 5.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

Authors:  L Buée; T Bussière; V Buée-Scherrer; A Delacourte; P R Hof
Journal:  Brain Res Brain Res Rev       Date:  2000-08

6.  Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Authors:  Paolo Zanotti-Fregonara; Adriaan A Lammertsma; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-19       Impact factor: 9.236

7.  Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Tetsuro Tago; Masahiro Maruyama; Makoto Higuchi; Takeo Yoshikawa; Hiroyuki Arai; Ren Iwata; Yukitsuka Kudo; Kazuhiko Yanai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-26       Impact factor: 9.236

8.  Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

Authors:  David T Chien; A Katrin Szardenings; Shadfar Bahri; Joseph C Walsh; Fanrong Mu; Chunfang Xia; William R Shankle; Alan J Lerner; Min-Ying Su; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.

Authors:  Christina S Hines; Jeih-San Liow; Paolo Zanotti-Fregonara; Jussi Hirvonen; Cheryl Morse; Victor W Pike; Robert B Innis
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

Review 10.  Imaging biomarkers in tauopathies.

Authors:  Melanie Dani; Paul Edison; David J Brooks
Journal:  Parkinsonism Relat Disord       Date:  2015-08-14       Impact factor: 4.891

View more
  5 in total

1.  Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles.

Authors:  Michel Koole; Talakad G Lohith; John L Valentine; Idriss Bennacef; Ruben Declercq; Tom Reynders; Kerry Riffel; Sofie Celen; Kim Serdons; Guy Bormans; Sandrine Ferry-Martin; Philippe Laroque; Abbas Walji; Eric D Hostetler; Richard J Briscoe; Jan de Hoon; Cyrille Sur; Koen Van Laere; Arie Struyk
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  An updated radiosynthesis of [18F]AV1451 for tau PET imaging.

Authors:  Andrew V Mossine; Allen F Brooks; Bradford D Henderson; Brian G Hockley; Kirk A Frey; Peter J H Scott
Journal:  EJNMMI Radiopharm Chem       Date:  2017-06-06

Review 3.  Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease.

Authors:  Caitlin V M L Jie; Valerie Treyer; Roger Schibli; Linjing Mu
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-30

4.  Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer's Disease.

Authors:  Ying Wang; Li Cai; Kaixiang Zhou; Mengchao Cui; Shaobo Yao
Journal:  Front Bioeng Biotechnol       Date:  2022-02-10

5.  Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC).

Authors:  Isaac M Jackson; So Jeong Lee; Alexandra R Sowa; Melissa E Rodnick; Laura Bruton; Mara Clark; Sean Preshlock; Jill Rothley; Virginia E Rogers; Leslie E Botti; Bradford D Henderson; Brian G Hockley; Jovany Torres; David M Raffel; Allen F Brooks; Kirk A Frey; Michael R Kilbourn; Robert A Koeppe; Xia Shao; Peter J H Scott
Journal:  EJNMMI Radiopharm Chem       Date:  2020-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.